Full Year 2023 Investor Presentation

121 Investor presentation Full year 2023 Insulin market size and volume market share in EMEA Insulin market share and market size (DKK billion) Total 48% Long- acting 41% Fast- 55% 12 acting 70% Premix 3 45% Human 2 19 Novo Nordisk Competitors ¹Market growth is YTD current vs YTD previous year; NN: Novo Nordisk Note: Share of growth not depicted due to too high numbers; Market values are based on the list prices Source: IQVIA, Nov 2023 LHS graph - Value, RHS Graph - Volume, MAT, Europe, Middle East & Africa Market growth1 A Market share 60% 35 -1.8% +0.2% 0.3% +0.3% 40% -0.3% +0.2% 20% Insulin volume: Market share -7.9% -0.9% 0% Nov 2020 -NN market share -15.2% +1.9% EMEA 10% 47% 5% -1% 0% -1% -5% -10% Nov 2023 Market growth (right axis) -NN growth (right axis)

View entire presentation